Cargando…

MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment

BACKGROUND: The bone marrow (BM) is the most common site of dissemination in patients with aggressive, metastatic neuroblastoma (NB). However, the molecular mechanisms underlying the aggressive behavior of NB cells in the BM niche are still greatly unknown. In the present study, we explored biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Gerique, Laura, García, Marta, Garrido-Garcia, Alícia, Gómez-González, Soledad, Torrebadell, Montserrat, Prada, Estela, Pascual-Pasto, Guillem, Muñoz, Oscar, Perez-Jaume, Sara, Lemos, Isadora, Salvador, Noelia, Vila-Ubach, Monica, Doncel-Requena, Ana, Suñol, Mariona, Carcaboso, Angel M., Mora, Jaume, Lavarino, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206243/ https://www.ncbi.nlm.nih.gov/pubmed/35715791 http://dx.doi.org/10.1186/s12885-022-09725-8

Ejemplares similares

AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia
por: Gonçalves-Alves, Eliana, et al.
Publicado: (2022)

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
por: Rodríguez-Hernández, Carlos J., et al.
Publicado: (2016)

DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis
por: Mayol, Gemma, et al.
Publicado: (2012)

Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients
por: Cuadrado‐Vilanova, Maria, et al.
Publicado: (2022)

Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
por: Winter, Ursula, et al.
Publicado: (2016)

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
por: García-Domínguez, Daniel Jose, et al.
Publicado: (2018)

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
por: Garcia, Idoia, et al.
Publicado: (2010)

EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping
por: Gómez-González, Soledad, et al.
Publicado: (2023)

Parathyroid hormone‐like hormone plays a dual role in neuroblastoma depending on PTH1R expression
por: García, Marta, et al.
Publicado: (2019)

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas
por: Castillo‐Ecija, Helena, et al.
Publicado: (2021)

Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
por: Acosta, Sandra, et al.
Publicado: (2009)

GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
por: Pascual-Pasto, Guillem, et al.
Publicado: (2022)

A MIF‐Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2
por: Krammer, Christine, et al.
Publicado: (2020)

Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma
por: Masvidal, Laia, et al.
Publicado: (2013)

Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report
por: Mora, Jaume, et al.
Publicado: (2023)

LGG-29. Use of Bevacizumab in Pediatric Low-grade Glioma: Ten-year experience in a single center
por: Rafael, Margarida Simão, et al.
Publicado: (2022)

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
por: Lavarino, Cinzia, et al.
Publicado: (2009)

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
por: Sánchez-Molina, Sara, et al.
Publicado: (2020)

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma
por: Mora, Jaume, et al.
Publicado: (2021)

DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
por: Gómez, Soledad, et al.
Publicado: (2015)

Expansive Oral Giant Cell Granuloma in a Pediatric Patient
por: Cahuana-Bartra, Pau, et al.
Publicado: (2023)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

CXCR4 and MIF are required for neutrophil extracellular trap release triggered by Plasmodium-infected erythrocytes
por: Rodrigues, Danielle A. S., et al.
Publicado: (2020)

Soluble CD74 Reroutes MIF/CXCR4/AKT‐Mediated Survival of Cardiac Myofibroblasts to Necroptosis
por: Soppert, Josefin, et al.
Publicado: (2018)

Dissecting the miR-451a-Mif Pathway in Endometriosis Pathophysiology Using a Syngeneic Mouse Model: Temporal Expression of Lesion Mif Receptors, Cd74 and Cxcr4
por: Nothnick, Warren B., et al.
Publicado: (2022)

Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain
por: Ye, Shaojing, et al.
Publicado: (2021)

Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review
por: Mora, Jaume
Publicado: (2022)

Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?
por: Garcia-Gerique, Laura, et al.
Publicado: (2023)

The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma
por: Zhang, Lin, et al.
Publicado: (2013)

Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4
por: Lacy, Michael, et al.
Publicado: (2018)

Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)

Epigenetic state determines inflammatory sensing in neuroblastoma
por: Wolpaw, Adam J., et al.
Publicado: (2022)

Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report
por: Martinez-Guzman, Marco Alonso, et al.
Publicado: (2018)

MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
por: Lee, Eun Ju, et al.
Publicado: (2022)

Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta
por: Faria, Miriam R, et al.
Publicado: (2010)

MIF magnifies malarial anemia
por: Van Epps, Heather L.
Publicado: (2006)

Detail Engineering Design T-MIF
por: Fusco, Y.
Publicado: (2014)

MIF: functions in brain and glioblastoma
por: Ohta, Shigeki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gmf6mu5ldocr2u54sqopn6trm9